Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,058 recalls, newest first

Class III · Low risk

Gatifloxacin Ophthalmic Solution

Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.

Terminated Stability / shelf life Lupin Pharmaceuticals Inc. NDC 68180-435-01 D-0326-2022
Class II · Moderate risk

Brinzolamide Ophthalmic Suspension

Defective Container: The notch in the cap that fits into the nozzle of the dropper could break off and block the dropper possibly resulting in the product not dispensing.

Terminated Packaging defect Teva Pharmaceuticals USA NDC 0591-2127-79 D-0373-2022
Class II · Moderate risk

Phenol

CGMP Deviations

Terminated cGMP deviation Edge Pharma, LLC NDC 05446-1211-03 D-0443-2022

Recalls by year